SKI Market

A+| A| A-|

Indian Indices

Sensex

76,664.21 -999.79
( -1.29%)

Global Indices

Nasdaq

49,249.13 -82.20
(-0.17%)

Dow Jones

7,185.72 56.32
(0.79%)

Hang Seng

59,744.07 603.84
(1.02%)

Nikkei 225

10,387.94 -69.07
(-0.66%)

Forex

USD-INR

94.05 0.29
(0.31%)

EUR-INR

109.99 0.01
(0.01%)

GBP-INR

126.84 0.17
(0.14%)

JPY-INR

0.59 0.00
(0.16%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Marksans Pharma Ltd

Industry : Pharmaceuticals - Indian - Formulations

BSE Code

ISIN Demat

Book Value()

524404

INE750C01026

32.9918134

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

MARKSANS

34.97

8621.44

EPS(TTM)

Face Value()

Div & Yield %

5.44

0.42

Back

Rail Vikas Nigam bags Rs 270 cr Central Railway project

Feb 25,2026

Rail Vikas Nigam has received letter of award (LOA) from Central Railway for 'Design, Supply, Erection, Testing & Commissioning of 220/132/55 KV Traction Substation, Sectioning post (SPs) and Sub sectioning post (SSPs) in 2 x 25 KV Traction System (Scott Connected Transformer) of Daund - Solapur Sections of Central Railway, to meet 3000 MT loading target on EPC mode.” The project cost is Rs 270.22 crore.

76,664.21 -999.79 ( -1.29%)

49,249.13 -82.20 (-0.17%)

7,185.72 56.32 (0.79%)

59,744.07 603.84 (1.02%)

10,387.94 -69.07 (-0.66%)

94.05 0.29 (0.31%)

109.99 0.01 (0.01%)

126.84 0.17 (0.14%)

0.59 0.00 (0.16%)